2009
DOI: 10.1517/14656560903304063
|View full text |Cite
|
Sign up to set email alerts
|

The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review

Abstract: Prevalence estimates varied, possibly owing to differences in diagnostic criteria and populations studied. Little is known about CLBP's economic burden. Treatment guidelines recommended multimodal treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
138
1
8

Year Published

2010
2010
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 208 publications
(149 citation statements)
references
References 17 publications
2
138
1
8
Order By: Relevance
“…They were found to be 3100 Euro and 17600 Euro, respectively. In our study, the high indirect cost was consistent with data of other countries (20)(21)(22)26). Our cases were most frequently the patients of outpatient clinics of physical therapy, while the second most frequently applied outpatient clinic was neurosurgery.…”
Section: Discussionsupporting
confidence: 91%
“…They were found to be 3100 Euro and 17600 Euro, respectively. In our study, the high indirect cost was consistent with data of other countries (20)(21)(22)26). Our cases were most frequently the patients of outpatient clinics of physical therapy, while the second most frequently applied outpatient clinic was neurosurgery.…”
Section: Discussionsupporting
confidence: 91%
“…The annual direct costs of LBP in Germany are estimated over €7000 per person. Sick leave at work accounted for 75% of the total cost per patient for LBP (Juniper, 2009). Neverthe-less, other authors support the concept that treating LBP is cost-effective (Moffett, 1999).…”
Section: Introductionmentioning
confidence: 97%
“…LBP has an enormous impact on individuals, families, communities, governments and businesses throughout the world (Hoy, 2010). In Italy where this research has been carried out 8.2% of the Italian population in 1999 suffered from LBP (ISTAT, 1999) and 13.5% reported regular use of analgesics or nonsteroidal anti-inflammatory drugs (NSAIDs) in the two weeks preceding the onset of LBP (Juniper, 2009). The economic burden of LBP is of considerable relevance.…”
Section: Introductionmentioning
confidence: 99%
“…The highest prevalence rates can be estimated for employees in the "mid-ages". Moreover, the major economic burden results from the high disability rates and the persistent recurrence of the preliminary cervical or lumbar pain [3,4]. As a large part of these disabilities are caused by specific job demands preventive strategies have to focus on the reduction of occupational stressors to avoid chronic episodes of back pain.…”
Section: Introductionmentioning
confidence: 99%